Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study

13 Jul 2016

Abstract excerpt

// Xiaohua Qian 1, * , Hua Tan 1, * , Jian Zhang 1 , Keqin Liu 1 , Tielin Yang 2 , Maode Wang 3 , Waldemar Debinskie 4 , Weilin Zhao 1 , Michael D. Chan 4 , Xiaobo Zhou 1 1 Department of Radiology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA 2 School of Life Science, Xi’an Jiaotong University, Xi’an, Shanxi 710049, China 3 The First Affiliated Hospital, Xi’an Jiaotong...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Colorectal Cancer Treatments and Studies
Share to Radiomics and Machine Learning in Medical Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27421136
DOI: 10.18632/oncotarget.10553

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics studyPMID 27421136Read ↗

Radiogenomics-based Risk Prediction of Glioblastoma Multiforme with Clinical RelevanceSemantic proximity Read ↗

IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy.Semantic proximity Read ↗

Distinction of pseudoprogression from true progression in glioblastomas using machine learning based on multiparametric magnetic resonance imaging and O6-methylguanine-methyltransferase promoter methylation statusSemantic proximity Read ↗

Exploring the prognostic value and biological pathways of transcriptomics and radiomics patterns in glioblastoma multiformeSemantic proximity Read ↗

The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma: A meta-analysis.Semantic proximity Read ↗

Integrative analysis of a Novel six methylated pseudogene Prognostic signature in patients with gliomaSemantic proximity Read ↗

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.Semantic proximity Read ↗

Biologic Pathways Underlying Prognostic Radiomics Phenotypes from Paired MRI and RNA Sequencing in Glioblastoma.Semantic proximity Read ↗

IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy.Semantic proximity Read ↗

NAPH-Fluorescence Lifetime Imaging informed machine learning modelling reliably predicts Temozolomide responsiveness in GlioblastomaSemantic proximity Read ↗

Is there pseudoprogression in secondary glioblastomas?Semantic proximity Read ↗

Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival dataSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.